2024-12-01 2025-11-30 2025-11-30 false 11696234 Oakfield Consortium Limited 64209Activities of other holding companies not elsewhere classified iso4217:GBP xbrli:pure 116962342024-12-01 116962342025-11-30 116962342024-12-01 2025-11-30 11696234bus:SmallEntities2024-12-01 2025-11-30 11696234bus:AuditExempt-NoAccountantsReport2024-12-01 2025-11-30 11696234bus:FullAccounts2024-12-01 2025-11-30 11696234core:WithinOneYear2025-11-30 11696234core:AfterOneYear2025-11-30 11696234core:WithinOneYear2024-12-01 2025-11-30 11696234core:AfterOneYear2024-12-01 2025-11-30 11696234core:CurrentFinancialInstruments2025-11-30 11696234core:Non-currentFinancialInstruments2025-11-30 11696234core:CurrentFinancialInstruments2024-12-01 2025-11-30 11696234core:Non-currentFinancialInstruments2024-12-01 2025-11-30 11696234core:LandBuildings2024-12-01 2025-11-30 11696234core:FurnitureFittings2024-12-01 2025-11-30 11696234core:OfficeEquipment2024-12-01 2025-11-30 11696234core:Vehicles2024-12-01 2025-11-30 11696234core:PlantMachinery2024-12-01 2025-11-30 11696234core:OtherPropertyPlantEquipment2024-12-01 2025-11-30 11696234core:LandBuildings2025-11-30 11696234core:PlantMachinery2025-11-30 11696234core:Vehicles2025-11-30 11696234core:FurnitureFittings2025-11-30 11696234core:OfficeEquipment2025-11-30 11696234core:OtherPropertyPlantEquipment2025-11-30 11696234core:Right-of-useAssets2024-12-01 2025-11-30 11696234core:Right-of-useAssets2025-11-30 11696234core:Goodwill2024-12-01 2025-11-30 11696234core:PatentsTrademarksLicencesConcessionsSimilar2024-12-01 2025-11-30 11696234core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-01 2025-11-30 11696234core:OtherResidualIntangibleAssets2024-12-01 2025-11-30 11696234core:Goodwill2025-11-30 11696234core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-11-30 11696234core:PatentsTrademarksLicencesConcessionsSimilar2025-11-30 11696234core:OtherResidualIntangibleAssets2025-11-30 11696234dpl:CostSales2024-12-01 2025-11-30 11696234dpl:AdministrativeExpenses2024-12-01 2025-11-30 11696234dpl:DistributionCosts2024-12-01 2025-11-3011696234core:ShareCapital2025-11-30 11696234core:SharePremium2025-11-30 11696234core:RevaluationReserve2025-11-30 11696234core:OtherReservesSubtotal2025-11-30 11696234core:ShareCapitalPreferenceShares2025-11-30 11696234core:CapitalRedemptionReserve2025-11-30 11696234core:OtherCapitalReserve2025-11-30 11696234core:RetainedEarningsAccumulatedLosses2025-11-3011696234core:ShareCapital2024-12-01 2025-11-30 11696234core:SharePremium2024-12-01 2025-11-30 11696234core:RevaluationReserve2024-12-01 2025-11-30 11696234core:OtherReservesSubtotal2024-12-01 2025-11-30 11696234core:RetainedEarningsAccumulatedLosses2024-12-01 2025-11-301169623412024-12-01 2025-11-30 1169623422024-12-01 2025-11-3011696234core:ShareCapital12024-12-01 2025-11-30 11696234core:ShareCapital22024-12-01 2025-11-3011696234core:SharePremium12024-12-01 2025-11-30 11696234core:SharePremium22024-12-01 2025-11-3011696234core:RevaluationReserve12024-12-01 2025-11-30 11696234core:RevaluationReserve22024-12-01 2025-11-3011696234core:RetainedEarningsAccumulatedLosses12024-12-01 2025-11-30 11696234core:RetainedEarningsAccumulatedLosses22024-12-01 2025-11-301169623412024-12-01 2025-11-3011696234core:Non-currentFinancialInstrumentscore:CostValuation2024-12-01 11696234core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-11-30 11696234core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-11-30 11696234core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-11-30 11696234core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2025-11-30 11696234core:Non-currentFinancialInstrumentscore:CostValuation2025-11-3011696234core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2024-12-01 11696234core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-11-30 11696234core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-11-30 11696234core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-11-30 11696234core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2025-11-30 11696234core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-11-30 11696234core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-11-3011696234core:Non-currentFinancialInstruments2025-11-30 11696234core:Non-currentFinancialInstruments2024-11-30116962342023-12-01 116962342024-11-30 116962342023-12-01 2024-11-30 11696234core:WithinOneYear2024-11-30 11696234core:AfterOneYear2024-11-30 11696234core:CurrentFinancialInstruments2024-11-30 11696234core:Non-currentFinancialInstruments2024-11-30 11696234core:LandBuildings2024-11-30 11696234core:PlantMachinery2024-11-30 11696234core:Vehicles2024-11-30 11696234core:FurnitureFittings2024-11-30 11696234core:OfficeEquipment2024-11-30 11696234core:OtherPropertyPlantEquipment2024-11-30 11696234core:Right-of-useAssets2024-11-30 11696234core:Goodwill2024-11-30 11696234core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-11-30 11696234core:PatentsTrademarksLicencesConcessionsSimilar2024-11-30 11696234core:OtherResidualIntangibleAssets2024-11-30 11696234dpl:AdministrativeExpenses2023-12-01 2024-11-3011696234core:ShareCapital2024-11-30 11696234core:SharePremium2024-11-30 11696234core:RevaluationReserve2024-11-30 11696234core:OtherReservesSubtotal2024-11-30 11696234core:ShareCapitalPreferenceShares2024-11-30 11696234core:CapitalRedemptionReserve2024-11-30 11696234core:OtherCapitalReserve2024-11-30 11696234core:RetainedEarningsAccumulatedLosses2024-11-3011696234core:RetainedEarningsAccumulatedLosses2023-12-01 11696234core:ShareCapital2023-12-01 11696234core:SharePremium2023-12-01 11696234core:RevaluationReserve2023-12-01 11696234core:ShareCapital2023-12-01 2024-11-30 11696234core:SharePremium2023-12-01 2024-11-30 11696234core:RevaluationReserve2023-12-01 2024-11-30 11696234core:OtherReservesSubtotal2023-12-01 2024-11-30 11696234core:RetainedEarningsAccumulatedLosses2023-12-01 2024-11-301169623412023-12-01 2024-11-30 1169623422023-12-01 2024-11-3011696234core:ShareCapital12023-12-01 2024-11-30 11696234core:ShareCapital22023-12-01 2024-11-3011696234core:SharePremium12023-12-01 2024-11-30 11696234core:SharePremium22023-12-01 2024-11-3011696234core:RevaluationReserve12023-12-01 2024-11-30 11696234core:RevaluationReserve22023-12-01 2024-11-3011696234core:RetainedEarningsAccumulatedLosses12023-12-01 2024-11-30 11696234core:RetainedEarningsAccumulatedLosses22023-12-01 2024-11-3011696234bus:Director12024-12-01 2025-11-3011696234bus:PrivateLimitedCompanyLtd2024-12-01 2025-11-30
Oakfield Consortium Limited
Unaudited Financial Statements
for the year ended 30 November 2025
Company registration number 11696234
(England and Wales)

Company Information

For the year ended 30 November 2025
Director Brennan, Robert Andrew

Registered office 3 Park Attwood Court Trimpley Lane
Shatterford
Bewdley
DY12 1DH

Registered number 11696234

Accountant KNB Consultants Limited
Suite A 82 James Carter Road
Mildenhall
Bury St Edmonds
IP28 7DE

Statement of Financial Position

As at 30 November 2025
Notes
2025
2024
£
£
£
£
Current assets
Debtors
4
95,000
75,000
Investments
5
380,228
400,000
Cash at bank and in hand
31,441
3,163
506,669
478,163
Creditors
Amounts falling due within one year
6
(3,120)
(2,005)
(3,120)
(2,005)
Net current assets (liabilities)
503,549
476,158
Total assets less current liabilities
503,549
476,158
Net assets (liabilities)
503,549
476,158
Capital and reserves
Called up share capital
11,733
11,733
Profit and loss account
491,816
464,425
Total equity
503,549
476,158

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the director on 19 August 2026 and are signed on its behalf by:

Brennan, Robert Andrew
Brennan, Robert Andrew
Director

Company registration number 11696234

Notes to the Financial Statements

For the year ended 30 November 2025

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

2.2. Employee benefits

Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.

2.3. Financial instruments

Election and recognition

The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.


Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.


Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in profit or loss.


If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.


Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.


Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.


Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled.

2.4. Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

3. Employees

The average number of employees during the year was 2 (2024: 2).

4. Debtors

2025
2024
£
£
Other debtors
95,000
75,000
Total due within one year
95,000
75,000
Total due after one year
-
-
Total
95,000
75,000

5. Current asset investments

2025
2024
£
£
Other investments
380,228
400,000
Total
380,228
400,000

6. Creditors due within one year

2025
2024
£
£
Directors loan account
1,620
220
Accruals and deferred income
1,500
1,785
Total
3,120
2,005

7. Related party transactions

Included within Other Creditors is the sum of £1,620 (2024: £220 owed from the director Mr Robert Brennan) owed to the director Mr Robert Brennan. This amount is interest free, and available on demand.

8. Controlling party

The ultimate controlling party is Mr Robert Brennan, by virtue of his majority shareholding.